Comparison of the safety of the standard dose and a higher dose of gadodiamide injection for MR imaging of the central nervous system
- 1 May 1994
- journal article
- clinical trial
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 4 (3) , 419-423
- https://doi.org/10.1002/jmri.1880040330
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.Radiology, 1993
- A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous systemNeuroradiology, 1993
- Gadodiamide Injection and Gadopentetate DimeglumineActa Radiologica, 1992
- Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.Radiology, 1992
- Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.Radiology, 1991
- Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.Radiology, 1991
- MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.Radiology, 1991
- Nonionic Magnetic Resonance Imaging Contrast Agents Clinical Trial Experience of Safety, Tolerance, and Efficacy of Gadodiamide InjectionInvestigative Radiology, 1990
- Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.Radiology, 1990
- Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.Radiology, 1990